Dr.Rajesh Raja Radhakrishnan

Catalyst Compass at MSMF, Narayana Health. We, theraCUES, have a stall at Catalyst Compass. Event happening at MSMF-TBI. Come and meet theraCUES team. Swastika Mandal Sai Krishna Akshay Ramesh to discuss any translational research projects. #oncology #neuro #spatialtranscriptomics

175

6 Comments

21 oncology topics in 1.5 days, with take-home algorithms - Yael Waknine Rohit Gosain, MD Rahul Gosain, MD, MBA Roswell Park Comprehensive Cancer Center #Cancer #OncoDaily #Oncology #UpstateNY #CancerSymposium

26

On August 16th, Taimei Technology co-organized the "Excellence in Clinical Strategy and Operations Summit" in Shanghai, alongside PharmaKo, under the guidance of the Shanghai Biopharmaceutical Industry Promotion Center. The event successfully brought together nearly 100 clinical operations professionals to discuss and share insights on efficient clinical operations in the era of globalized clinical research. Gary MA, Senior Vice President of Taimei Technology, emphasized in his keynote: "Chinese pharmaceutical companies face multiple challenges in global digitalization. A clear long-term strategy, sustained digital investment, and the right digital partners are essential. With reliable R&D capabilities, cost-effective solutions, sustainable investments, and exceptional responsiveness, we are committed to supporting companies on their global journey." We have established three global delivery centers, providing cutting-edge digital solutions across over 200 international projects. Our localized, multi-time zone, and multilingual support ensures seamless and reliable assistance for the global expansion of innovative pharmaceuticals. Driven by a commitment to pioneering digital transformation, we foster strategic partnerships that empower pharmaceutical companies to thrive on the world stage. #TaimeiTechnology #eClinicalSolutions #DigitalTransformation #ClinicalResearch #Globalization #EDC #eCollect6 #TaimeieCollect6 #AI #Partnership #ClinicalTrials

4

#ICYMI: check out our latest Q&A with Dr. Binita Shrivastava Tunga, Co-founder of Ameliorate Biotech Pvt Ltd where she delves into the burden of mosquito-borne diseases, how point-of-care diagnostics, including the ASSURED test that her team has developed, are the need of the hour, and more in #VectorBorneDiseases. Read the full article here: https://lnkd.in/duFuzEvM #IndiaHealthFund #Malaria #RollBackMalaria #FeverPanel

2

International Biotherapy Institute ttps://biotherapy.institute/en began production of its own biopharmaceutical products in India https://arecur.com/en https://arecur.in/ https://lnkd.in/dp72bDeD To promote our products in the Indian online market, we are looking for a company (person) with experience in medical/pharmaceutical online marketing that meets the following positions - not a dreamer, he has worked and has real successful cases - understands that the most important thing is the sales result and not penetration statistics, leads and likes - ready to adequately justify the financial budget for promotion, and not senselessly spend money hoping for a lucky break - if there is mutual understanding and success in promoting products in India, partnership in the project may be offered

7

✍️Sun-Shining - reading Indian Pharmaceutical Industry mind : '.."The mindset in India is that if Pfizer can do something, it will be difficult for us to do but if another Indian company can do it, we can also do it," he said, adding that he sees a "positive cascade" as companies start to see they can make money from innovation. Among other Indian drug makers that have invested in innovative research are ...' - Extract #economictimes #india #indianpharma #skdscans

1

Success??? Here the successful story of biotech company by Reetu Yadav. Kiran Mazumdar-Shaw, an Indian entrepreneur, founded Biocon, one of the largest biotechnology companies in Asia, despite facing numerous challenges early in her career. Early Life and Education Kiran was passionate about science from an early age and wanted to become a brewmaster, inspired by her father, who was a brewmaster himself. After graduating with a degree in Zoology, she pursued a brewing course in Australia and earned a Master’s degree in Malting and Brewing. Despite this, when she returned to India, she struggled to find a job in the brewing industry as it was male-dominated, and no company was willing to hire a woman for the role. Turning Adversity into Opportunity Kiran could have given up on her dreams, but she instead turned her attention to biotechnology, which was in its infancy in India at the time. In 1978, she founded Biocon in her garage with a small seed investment and a vision to leverage biotechnology to produce enzymes and, later, pharmaceuticals that could benefit society. Challenges and Breakthroughs In the early days, Kiran faced skepticism from banks, clients, and partners. She struggled with infrastructure, funding, and finding skilled employees. Yet, she persevered, investing in research and innovation. One of Biocon’s major breakthroughs was the development of India’s first recombinant insulin, which made life-saving insulin more affordable for diabetic patients. Her determination paid off, and Biocon became a leader in the biotech industry. The company went public in 2004, making Kiran the wealthiest self-made woman in India at that time. Today, Biocon continues to innovate in the field of biotechnology, focusing on affordable healthcare solutions for diseases like cancer, diabetes, and autoimmune disorders. Key Lessons for Biotech Students: Passion Drives Innovation: Kiran’s passion for science and innovation led her to create solutions that have impacted millions of lives. Perseverance Through Challenges: Despite numerous hurdles, from gender bias to financial struggles, Kiran didn’t give up on her dreams. Value of Science for Society: Biocon’s focus on creating affordable drugs highlights how biotech can address critical global health challenges. Embrace New Opportunities: Kiran shifted her career focus from brewing to biotechnology, showing that adaptability is key to success. Conclusion Kiran Mazumdar-Shaw’s journey from being denied a job as a brewmaster to becoming a global biotech leader is an inspiring reminder that success in biotechnology requires resilience, creativity, and a commitment to making a difference. For biotech students, her story exemplifies how scientific knowledge, combined with entrepreneurial spirit, can transform industries and improve lives. hashtag#labexperts hashtag#inhanceknowladge hashtag#scientist hashtag#sciencememes hashtag#sciencefacts hashtag#laboratorylife hashtag#labtechnologist hashtag#laboratorywork

3

Hypothyroidism click to know more https://lnkd.in/gqHMX8R4 Get accurate reports at NANDITA DIAGNOSTICS, DAVANAGERE, Contact: 7090905511 #davanagere #davanagere_the_smart_city #nammadavangere #davanagereofficial #trendsofdavangere #hypothyroidism #hypothyroidismawareness #thyroid #drnandish

3

Discover strategies to overcome matrix effects, endogenous interference, and calibration difficulties in our new whitepaper. Utilize high-resolution mass spectrometry (HRMS) for enhanced detail and specificity in any animal matrix, empowering your research endeavors. #highresolution #biotech #immunotherapy #pharma #fda

4

OHT's Dr. Ramanan Laxminarayan spoke on an expert panel discussion on global strategies for defeating antimicrobial resistance with Dame Sally Davies and Anand Anandkumar of Bugworks Research Inc. at the Devex news summit on the sidelines of UNGA 79. In Devex's coverage of the event, Ramanan cites that three things are needed to curb the AMR crisis, "First, there’s a need for stronger infection prevention efforts in low- and middle-income countries, such as clean water and adequate sanitation. Second, there’s a need to expand access to antibiotics to settings where people are dying without the needed drugs. Third, there’s a need for a new pipeline of antibiotics." Read more and watch the recording of the panel here: https://lnkd.in/d9h5aUvZ #AntimicrobialResistance #GlobalHealth #AccessToMedicine #UNGA79 #DevexNews

9

Hypothyroidism click to know more https://lnkd.in/gXZT7k4b Get accurate reports at NANDITA DIAGNOSTICS, DAVANAGERE, Contact: 7090905511 #davanagere #davanagere_the_smart_city #nammadavangere #davanagereofficial #trendsofdavangere #hypothyroidism #hypothyroidismawareness #thyroid #drnandish

2

Expand your knowledge horizon with J Mitra Scientific Seminar (JSS). From emerging trends to best practices, our seminars cover it all. https://zurl.co/ck2T #JSS #Jmitra #Biotech #BioTechnology

3

1 Comment

"Huonslab Completes IND Submission for Recombinant Human Hyaluronidase Drug Delivery Agent" - "HyDIFFUZE™: Advancing Towards the World's First Biosimilar(Stand-alone) with Ample Competitive Edge" - Huonslab, a subsidiary of Huons Global, is accelerating the development of recombinant human hyaluronidase. Huonslab announced on the 29th that it completed non-clinical toxicity studies on HyDIFFUZE™ (HLB3-002), a recombinant human hyaluronidase currently under development, and applied for an IND to Korea Ministry Food and Drug Safety (Korea MFDS).  Huonslab conducted all essential non-clinical toxicity assessments mandated for the IND through eminent domestic and international Contract Research Organizations (CROs), ensuring safety across all criteria. HyDIFFUZE™, which is being developed by Huonslab, features naturally derived recombinant human hyaluronidase and has the same amino acid sequence as Hylenex®, the hyaluronidase of Halozyme, the original drug. In September of last year, a comparative evaluation was conducted through a domestic CRO organization between MabThera® IV, containing HyDIFFUZE™, and MabThera® SC, the original drug containing Hylenex® administered by subcutaneous injection to animals. The results confirmed the similarity between the two formulations, demonstrating equivalent pharmacokinetics and diffusion efficacy. Chae-young Lim, the executive director of Bio Research at Huonslab, remarked, "Through our non-clinical stdudies, we've established the efficacy and safety of HyDIFFUZE™ .We've completed the manufacturing of drug substance and product for clinical trials, and have submitted an IND application to Korea MFDS. He further noted, "The expiration of the patent for Hylenex®, the original product of Halozyme, in Korea and Europe in March this year, with the U.S. patent set to expire in September 2027, marks a significant milestone." Lim continued “Upon the completion of clinical trials for our proprietary product, HyDIFFUZE™, and subsequent product approval by the end of 2025, we expect to secure sufficient global competitiveness” He added, "HyDIFFUZE™ will be utilized as a product in the fields of dermatology, pain management, and edema treatment. Furthermore, we aim to accelerate the development of subcutaneous drug delivery by leveraging our HyDIFFUZE™ platform as a drug diffusion enhancer, thereby expanding its utility and enhancing convenience." Meanwhile, Huonslab is pioneering the development of the world's first biosimilar (stand-alone) of Hilenex®, a drug diffusion facilitator that enables the conversion of current intravenous injections to subcutaneous injections.

4

Introducing High-Throughput Proteomics in India - Measure 11,000 proteins from 50ul serum / blood Excited to delve into the world of high-throughput proteomics with Genotypic? Join us for an enlightening webinar where we'll unravel the significance of high-throughput proteomics in India. One can measure expression levels of 11K human proteins starting from just 50uL of serum / plasma. 📅 Date: June 6th, 2024 🕒 Time: 3 PM IST | 5:30 PM Singapore Highlights: 1. What high-throughput proteomics is and why it matters 2. How Genotypic is revolutionizing proteomics in India 3. Real-world applications and success stories 4. Opportunities for collaboration and growth Register here: https://lnkd.in/gNufBFa7

26

Team Growdea Technologies Pvt Ltd has published a fascinating article on using machine learning and computational modeling to differentiate between stable and unstable proteins. Our innovative approach has the potential to design advance algorithms to detect harmful mutations in proteins and design better protein analogues with higher thermal stability. This research could have a significant impact on the field of protein engineering and contribute to the development of more effective treatments for a variety of diseases. #MachineLearning #MDSimulation #ComputationalModeling #ProteinEngineering #Bioinformatics #DataScience #ArtificialIntelligence #Biotechnology #Pharmaceuticals #ResearchAndDevelopment

59

5 Comments

LifeCell International Pvt.Ltd International, India’s Largest Cord Blood Bank - https://lnkd.in/gHrqyvaM LifeCell is India’s largest cord blood bank, offering stem cell banking services and diagnostic testing. Established in 2004, its BabyCord program is one of the largest cord blood banking programs in the region, with 50,000+ parents preserving newborn stem cells each year and 375,000 units cryopreserved. I had the privilege of interviewing Mr. Mayur Abhaya Srisrimal, Chief Executive Officer and Managing Director of LifeCell. Mr. Abhaya has led LifeCell since 2008 and been instrumental in expanding its stem cell storage services across India with its BabyCord program. Under his leadership, LifeCell also raised growth capital from Helion Ventures and extended its preventive diagnostic services by launching BabyShield, a program targeted at reducing the infant mortality ratio. LifeCell was founded in 2004, making it India's first private stem cell bank. It remains the largest stem cell bank in the country today. India currently has a population of 1.437 billion people and a fertility rate of 2.4 births per woman. Together, China and India house an astounding one-third of the world's total population. This makes India an absolutely critical cord blood and tissue banking market to watch. In this interview, we discuss LifeCell’s stem cell banking program, the company’s rapid growth, and cord blood market dynamics within India. #cordblood #cordtissue #stemcells #HSCT #perinatal *Note: I believe in clarity around communication and its source. This post was written by me, not artificial intelligence (AI).

7

"Shoutout to Outline India for spotlighting the eLAJ program!" Coming from a data-conscious organization like yours, this recognition for our tech-powered, data-driven, and community-centric approach to primary healthcare means a lot. The eLAJ program is constantly evolving. We're on a learning journey, adding features incrementally and adapting as we go. In the eLAJ program, innovation thrives in challenging environments. Through strong community partnerships and field staff tenacity, we pilot solutions that triumph over healthcare disparities. #preventivehealthcare #healthcareinnovation #primaryhealthcare #publichealth #HealthcareEquity

39

11 Comments

#Manufacturing/ #marketing of #ANTIBIOTICS may be regulated. #prescription to be mandatory. Central Govt considering to take manufacturing licensing powers of all antibiotics through New Drug route! How #AMR develops : AMR occurs when microorganisms (#bacteria, #viruses, #fungi, #parasites) develop mechanisms to resist the effects of antimicrobial drugs (#antibiotics, #antivirals, #antifungals), making them ineffective against infections. Causes of AMR: 1.⁠ ⁠Overuse and misuse of antimicrobials 2.⁠ ⁠Inadequate dosing and treatment duration 3.⁠ ⁠Lack of new antimicrobial development 4.⁠ ⁠Poor infection control practices 5.⁠ ⁠Agricultural use of antimicrobials #cdsco #mohfw #icmr #amr #antibiotics #ndctr #ndctr2019 #dtab #dcc

36

1 Comment

India's Drug Regulatory System Acknowledgments Worldwide... #CDSCO and #DCGI are key players in India's drug #regulatory system, ensuring #safety and #efficacy of drugs, vaccines, and #medicaldevices. ➡Global Recognition of the #IndianPharmacopoeia (IP) ➡A Rich Landscape of #clinicaltrials Using Cutting-Edge Technologies ➡Meeting the International Standards for Vaccine Regulation India's vaccine regulatory system has achieved World Health Organization Global Benchmarking Tool (GBT) #compliance, making it a key player in the global pharmaceutical landscape. With 36 major vaccine manufacturing facilities and 150 countries, India's commitment to #quality, #safety, and #innovation positions it as a global supplier of vaccines. #production #medicalaffairs #pharmamanufacturing #health #pharmacovigilance #medicalwriting #phama #pharmaotc #purachasemanager #zonalsalesmanager #pharmalinkin #pharmasales #regionalsalesmanager #areasalesmanager #medicalrepresentative #researchanddevelopment #biotech #medicalresearch #pharmaceutical #nursing #clinicaldatamanagement #drug #pharmacists #drugdevelopment #regulatoryaffairs #qualityassurance #qualitycontrol #clinicaltrials #clinicalresearch

4